Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Tenofovir Alafenamide Fumarate in Hepatitis B: NCT07253220 Clinical Landscape Report 2026
16 October 2026
NCT07253220 clinical landscape for Hepatitis B: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dimebolin hydrochloride in Dementia due to Alzheimer's disease (disorder): NCT07251023 Clinical Landscape Report 2026
16 October 2026
NCT07251023 clinical landscape for Dementia due to Alzheimer's disease (disorder): endpoints, sponsor, phase, geography, readouts, asset context and developm…
9 min read
Pumitamig in Pancreatic Ductal Adenocarcinoma: NCT07255404 Clinical Landscape Report 2026
16 October 2026
NCT07255404 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
GFH-375 in Solid tumor: NCT07259590 Clinical Landscape Report 2026
16 October 2026
NCT07259590 clinical landscape for Solid tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Pancreatic adenocarcinoma metastatic: NCT07259317 Clinical Landscape Report 2026
16 October 2026
NCT07259317 clinical landscape for Pancreatic adenocarcinoma metastatic: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Adalimumab in Crohn Disease: NCT07258641 Clinical Landscape Report 2026
16 October 2026
NCT07258641 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Methylprednisolone sodium succinate in Colitis, Ulcerative: NCT07257588 Clinical Landscape Report 2026
16 October 2026
NCT07257588 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Methylprednisolone in Colitis, Ulcerative: NCT07258771 Clinical Landscape Report 2026
16 October 2026
NCT07258771 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apatinib Mesylate in Advanced Hepatocellular Carcinoma: NCT07267806 Clinical Landscape Report 2026
16 October 2026
NCT07267806 clinical landscape for Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Iparomlimab/Tuvonralimab in Hepatocellular Carcinoma: NCT07268131 Clinical Landscape Report 2026
16 October 2026
NCT07268131 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GFH-375 in KRAS G12D mutation pancreatic cancer: NCT07262567 Clinical Landscape Report 2026
16 October 2026
NCT07262567 clinical landscape for KRAS G12D mutation pancreatic cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Florbenazine F18 in Parkinson Disease: NCT07265596 Clinical Landscape Report 2026
16 October 2026
NCT07265596 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.